We are live on
!
Find out more
HighTower Advisors Portfolio holdings
AUM
$94.2B
1-Year Est. Return
21.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+21.24%
3 Year Est. Return
+66.34%
5 Year Est. Return
+83.36%
10 Year Est. Return
+290.31%
AUM
$64.7B
AUM Growth
+$2.95B
(+4.8%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.8%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
3,995
New
390
Increased
1,526
Reduced
1,536
Closed
329
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$463M |
| 2 |
ExxonMobil
XOM
|
+$326M |
| 3 |
RTX Corp
RTX
|
+$222M |
| 4 |
Target
TGT
|
+$108M |
| 5 |
Whirlpool
WHR
|
+$96.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$308M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$54.3M |
| 4 |
Apple
AAPL
|
+$44.3M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$40.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.26% |
| 2 | Financials | 9.5% |
| 3 | Healthcare | 6.23% |
| 4 | Consumer Discretionary | 6.19% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
NovaGold Resources
NG
$2.61B
| $48K | ﹤0.01% |
+14,409
| New | +$47.8K |
|
|
FGNX
3302
FG Nexus Inc
FGNX
$37M
| $47K | ﹤0.01% |
396
| – | – |
|
3303
SSR Mining
SSRM
$5.51B
| $47K | ﹤0.01% |
+10,544
| New | +$54.1K |
|
3304
PUT
Yum China
YUMC
$15.3B
| $46.9K | ﹤0.01% |
10,000
-3,000
| -23% | -$110K |
|
3305
Heron Therapeutics
HRTX
$88.1M
| $45K | ﹤0.01% |
12,529
-30,000
| -71% | -$92.2K |
|
3306
Lantronix
LTRX
$238M
| $45K | ﹤0.01% |
12,853
| – | – |
|
3307
Lightwave Logic
LWLG
$903M
| $45K | ﹤0.01% |
15,000
-1,964
| -12% | -$7.18K |
|
3308
Expensify
EXFY
$172M
| $44K | ﹤0.01% |
+29,406
| New | +$46.4K |
|
3309
MiNK Therapeutics
INKT
$54.3M
| $43K | ﹤0.01% |
5,069
-19
| -0.4% | -$185 |
|
|
MAPS
3310
DELISTED
WM TECHNOLOGY INC A
MAPS
| $43K | ﹤0.01% |
40,191
+14,891
| +59% | +$16.4K |
|
|
MOND
3311
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $43K | ﹤0.01% |
17,714
| – | – |
|
3312
AbCellera Biologics
ABCL
$1.63B
| $42K | ﹤0.01% |
13,986
-30,088
| -68% | -$114K |
|
3313
Seres Therapeutics
MCRB
$48.8M
| $40K | ﹤0.01% |
2,750
+2,000
| +267% | +$33.4K |
|
3314
PMV Pharmaceuticals
PMVP
$63.5M
| $40K | ﹤0.01% |
25,030
| – | – |
|
3315
Altimmune
ALT
$554M
| $39K | ﹤0.01% |
+5,864
| New | +$43.3K |
|
|
TELL
3316
DELISTED
Tellurian Inc.
TELL
| $39K | ﹤0.01% |
55,266
-3,600
| -6% | -$1.99K |
|
3317
CALL
SentinelOne
S
$6.23B
| $38.9K | ﹤0.01% |
10,000
| – | – |
|
3318
CALL
Snowflake
SNOW
$92.4B
| $38.4K | ﹤0.01% |
3,000
+2,300
| +329% | +$340K |
|
3319
Cognition Therapeutics
CGTX
$83.3M
| $38K | ﹤0.01% |
22,962
| – | – |
|
3320
Banco Bradesco
BBD
$38.4B
| $37K | ﹤0.01% |
18,032
-11,833
| -40% | -$30.6K |
|
3321
Fate Therapeutics
FATE
$283M
| $37K | ﹤0.01% |
11,204
+104
| +0.9% | +$455 |
|
3322
Martin Midstream Partners
MMLP
$97.8M
| $37K | ﹤0.01% |
11,388
+17
| +0.1% | +$50 |
|
3323
Vanda Pharmaceuticals
VNDA
$318M
| $37K | ﹤0.01% |
+6,480
| New | +$33.5K |
|
3324
CALL
ProShares UltraPro Short QQQ
SQQQ
$2.12B
| $36.5K | ﹤0.01% |
12,804
-6,876
| -35% | -$1.75M |
|
3325
Cardiff Oncology
CRDF
$64.6M
| $36K | ﹤0.01% |
16,035
-1,965
| -11% | -$7.41K |
|
Similar funds
HighTower Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, HighTower Advisors held 3,995 positions worth $64.7B, up 4.8% from $61.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
HighTower Advisors deployed $2.46B of net new capital in Q2 2024, opening 390 new positions and adding to 1,526 existing holdings. Its largest new stake was Invesco QQQ Trust: 1,029,639 shares worth $493M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $125M trimmed.
- HighTower Advisors's largest Q2 2024 buy was Invesco QQQ Trust: 1,029,639 shares worth $493M.
- HighTower Advisors added most to ExxonMobil in Q2 2024, an estimated $326M increase.
- HighTower Advisors's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $125M.
- HighTower Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $308M.
- HighTower Advisors's ten largest holdings make up 19% of its $64.7B portfolio in Q2 2024.
- HighTower Advisors opened 390 new positions and closed 329 in Q2 2024.
- HighTower Advisors's portfolio value rose 4.8% quarter-over-quarter to $64.7B.
Based on HighTower Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.